RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Items 201–300 of 1,009
Cell and molecular biology of the multifunctional peptide, adrenomedullin
López, J., & Martínez, A. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)21010-4 · Cited by 159
RAMPs: accessory proteins for seven transmembrane domain receptors
Foord, S. M., & Marshall, F. H. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01347-4 · Cited by 151
Self-citationSorby-Adams, A., Marcoionni, A., Dempsey, E., Woenig, J., & Turner, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081788 · Cited by 144
“Calcitonin receptor-like receptor (CLR) is the receptor to which CGRP binds, comprised of two separate structures which come together, the G protein coupled receptor and CLR which is an accessory protein identified as receptor activity modifying protein (RAMP) [129].”
BackgroundEdvinsson, L. I. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2018_201 · Cited by 150
Dackor, R. T., Fritz-Six, K., Dunworth, W. P., Gibbons, C. L., Smithies, O., & Caron, K. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2511-2518.2006 · Cited by 146
“Briefly, McLatchie et al. demonstrated that association with RAMP1 made CLR bind preferentially to CGRP, while association of CLR with RAMP2 or RAMP3 made it bind to AM ( 39 ).”
BackgroundResultSalter-Cid, L., Brunmark, A., Li, Y., Leturcq, D., Peterson, P. A., Jackson, M. R., & Yang, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5434 · Cited by 152
Salvatore, C., Hershey, J. C., Corcoran, H. A., Fay, J. F., Johnston, V. K., Moore, E. L., Mosser, S. D., Burgey, C. S., Paone, D. V., Shaw, A. W., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130344 · Cited by 161
“MK-0974 displayed little to no affinity for the human adrenomedullin receptors as measured by the ability to compete with 125I-human adrenomedullin, with Ki values of 100 and 29 M on CLR/RAMP2 and CLR/RAMP3, respectively.”
BackgroundInfluentialFernández-Larrea, J., Merlos‐Suárez, A., Ureña, J. M., Baselga, J. M., & Arribas, J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80470-0 · Cited by 148
Cloning and functional expression of GABAB receptors from Drosophila
Mezler, M., Müller, T., & Raming, K. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01410.x · Cited by 145
“It is conceivable that receptor-activity-modifying proteins like RAMPs (McLatchie et al., 1998), which are cofactors for the calcitonin-receptor-like receptor (CGRP), or postsynaptic anchoring proteins, equivalent to Homer (Brakeman et al., 1997), are needed for D-GABABR3 functioning.”
BackgroundAdrenomedullin and tumour angiogenesis
Nikitenko, L. L., Fox, S. B., Kehoe, S. T., REES, M. C. P., & Bicknell, R. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602832 · Cited by 160
“Adrenomedullin has been shown to be involved in carcinogenesis and tumour progression by promoting tumour proliferation, angiogenesis and the inhibition of apoptosis.”
InfluentialEndogenous Allosteric Modulators of G Protein–Coupled Receptors
van der Westhuizen, E. T., Valant, C., Sexton, P. M., & Christopoulos, A. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221606 · Cited by 146
Blanpain, C., Wittamer, V., Vanderwinden, J., Boom, A., Renneboog, B., Lee, B., Poul, E. L., Asmar, L. E., Govaerts, C., Vassart, G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100583200 · Cited by 146
Martínez, A., Oh, H.-R., Unsworth, E. J., Bregonzio, C., Saavedra, J. M., Stetler‐Stevenson, W. G., & Cuttitta, F. F. (2004) · Biochemical Journal · doi:10.1042/bj20040920 · Cited by 145
Fernandez-Sauze, S., Delfino, C., Mabrouk, K., Dussert, C., Chinot, O. L., Martin, P., Grisoli, F., Ouafik, L., & Boudouresque, F. (2004) · International Journal of Cancer · doi:10.1002/ijc.11663 · Cited by 153
Ouafik, L., Fernandez-Sauze, S., Boudouresque, F., Chinot, O. L., Delfino, C., Fina, F., Vuaroqueaux, V., Dussert, C., Palmari, J., Dufour, H., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62555-2 · Cited by 147
“reactivities against the following peptides were observed: [ACTH (1-24), endothelin-1, AVP, CRF, TRH, substance P, and ANF].”
BackgroundCGRP antagonists: unravelling the role of CGRP in migraine
Doods, H. N., Arndt, K., Rudolf, K. D., & Just, S. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.005 · Cited by 144
Boyle, C. N., Lutz, T. A., & Le Foll, C. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2017.11.009 · Cited by 142
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
BackgroundRecognizing the role of CGRP and CGRP receptors in migraine and its treatment
Edvinsson, L. I., & Warfvinge, K. (2017) · Cephalalgia · doi:10.1177/0333102417736900 · Cited by 141
Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
Geven, C., Kox, M., & Pickkers, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00292 · Cited by 135
“The endothelial adrenomedullin-RAMP2 system regulates vascular integrity and suppresses tumour metastasis.”
BackgroundInfluentialCalcitonin gene‐related peptide in the joint: contributions to pain and inflammation
Walsh, D. A., Mapp, P. I., & Kelly, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12669 · Cited by 144
Gut hormones: Implications for the treatment of obesity
Neary, M. T., & Batterham, R. L. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.005 · Cited by 158
“Instead, amylin binds to the calcitonin receptor with tissue specificity being conferred by receptor activity modifying proteins (RAMPs) binding to the receptor (Chen et al., 1997; McLatchie et al., 1998; Christopoulos et al., 1999).”
BackgroundTrincot, C. E., Xu, W., Zhang, H., Kulikauskas, M. R., Caranasos, T. G., Jensen, B. C., Sabine, A., Petrova, T. V., & Caron, K. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313835 · Cited by 144
“As a protein that signals through a GPCR (G-protein coupled receptor), CLR (calcitonin receptor-like receptor; Calcrl=gene) with specific coreceptor RAMP2 (receptor-activity modifying protein 2), adrenomedullin is an ideal candidate for a druggable biological target.(69) In conclusion, our data show an endogenous lymp…”
BackgroundControl of energy homeostasis by amylin
Lutz, T. A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0905-1 · Cited by 148
Hilairet, S., Bélanger, C., Bertrand, J., Laperrière, A., Foord, S. M., & Bouvier, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107323200 · Cited by 136
Self-citationDimerization of G-Protein-Coupled Receptors
Dean, M. K., Higgs, C., Smith, R. E., Bywater, R. P., Snell, C. R., Scott, P. D., Upton, G. J. G., Howe, T. J., & Reynolds, C. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010290+ · Cited by 138
Martin, S. S., Navarro, V., Vincent, J. P., & Mazella, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36000 · Cited by 137
Dimerization and Domain Swapping in G-Protein-Coupled Receptors A Computational Study
Gouldson, P. R., Higgs, C., Smith, R. E., Dean, M. K., Gkoutos, G. V., & Reynolds, C. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00153-6 · Cited by 137
“1999) or heterodimerization to proteins other than GPCRs such as receptor-activity-modifying proteins (RAMPs) (Fraser et al. 1999; McLatchie et al. 1998).”
BackgroundModulation of Dopamine D2 Receptor Signaling by Actin-Binding Protein (ABP-280)
Li, M., Bermak, J. C., Wang, Z. W., & Zhou, Q. Y. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.3.446 · Cited by 151
“Moreover, a family of single-transmembrane-domain proteins has been identified as modifying proteins for calcitoninreceptor-like receptors (McLatchie et al., 1998).”
BackgroundTsujikawa, K., Yayama, K., Hayashi, T., Matsushita, H., Yamaguchi, T., Shigeno, T., Ogitani, Y., Hirayama, M., Kato, T., Fukada, S.-I., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705974104 · Cited by 136
Hay, D. L., Howitt, S. G., Conner, A. C., Schindler, M., Smith, D. M., & Poyner, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705472 · Cited by 132
“There is a considerable lack of information on this receptor complex although AM stimulates cyclic AMP production with similar potency to its actions at CL/RAMP2 (McLatchie et al., 1998; Aiyar et al., 2001; 2002; Kuwasako et al., 2002).”
BackgroundResultInfluentialKim, W., Moon, S.-O., Sung, M. J., Kim, S. H., Lee, S., So, J.-N., & Park, S. K. (2003) · The FASEB Journal · doi:10.1096/fj.02-1209fje · Cited by 132
“In addition, the functional AM receptor, composed of calcitonin receptor-like receptor (CRLR) and the receptor activity-modifying protein (RAMP) 2 or RAMP 3 is found in vascular endothelial cells (7, 8).”
BackgroundNeuromediators—a crucial component of the skin immune system
Luger, T. A. (2002) · Journal of Dermatological Science · doi:10.1016/s0923-1811(02)00103-2 · Cited by 135
“RAMP1 expression together with CRLR creates CGRP receptors whereas RAMP2/3-transported CRLR results in the cell surface expression of ADM receptors [11].”
BackgroundMorfis, M., Tilakaratne, N., Furness, S. G. B., Christopoulos, G., Werry, T. D., Christopoulos, A., & Sexton, P. M. (2008) · Endocrinology · doi:10.1210/en.2007-1735 · Cited by 134
Hargreaves, R. J., & Olesen, J. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13510 · Cited by 140
“RAMP1 is itself a member of a family of proteins that includes RAMP2 and RAMP3.”
BackgroundAdrenomedullin and PAMP: Discovery, structures, and cardiovascular functions
Kitamura, K., Kangawa, K., & Eto, T. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10052 · Cited by 142
“The protein was cloned as a receptor activity modifying protein (RAMP1) (McLatchie et al., 1998).”
BackgroundInfluentialPotent and Selective Human β3-Adrenergic Receptor Antagonists
Candelore, M. R., Deng, L., Tota, L. M., Guan, X.-M., Amend, A., Liu, Y., Newbold, R., Cascieri, M. A., & Weber, A. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34946-8 · Cited by 133
Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology
Marchese, A., George, S. R., Kolakowski, L. F., Lynch, K. R., & O’Dowd, B. F. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01366-8 · Cited by 156
Role of Nitric Oxide–cGMP Pathway in Adrenomedullin-Induced Vasodilation in the Rat
Hayakawa, H., Hirata, Y., Kakoki, M., Suzuki, Y., Nishimatsu, H., Nagata, D., Suzuki, E., Kikuchi, K., Nagano, T., Kangawa, K., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.689 · Cited by 135
Calcitonin gene-related peptide as inflammatory mediator
Springer, J., Geppetti, P., Fischer, A., & Groneberg, D. A. (2003) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/s1094-5539(03)00049-x · Cited by 131
Morinville, A., Cahill, C. M., Esdaile, M. J., Aibak, H., Collier, B., Kieffer, B. L., & Beaudet, A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04888.2003 · Cited by 146
“, 2001), or RAMP-1 (receptor activity modifying protein 1) for the calcitonin receptor-like receptor (CRLR; McLatchie et al., 1998), can assist in the proper folding of proteins and/or trafficking of GPCRs to the plasma membrane.”
BackgroundKamitani, S., Asakawa, M., Shimekake, Y., Kuwasako, K., Nakahara, K., & Sakata, T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00358-0 · Cited by 128
Ma, W., Chabot, J. ‐., Powell, K. J., Jhamandas, K. H., Dickerson, I. M., & Quirion, R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00159-3 · Cited by 137
“( McLatchie et al., 1998 ), and a coupling protein for signal transduction (RCP) (Evans et al., 2000; Prado et al., 2001).”
BackgroundOliver, K. R., Wainwright, A., Edvinsson, L. I., Pickard, J. D., & Hill, R. G. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200205000-00014 · Cited by 133
“…suggest that the cell surface expression and pharmacology of this G-protein–coupled receptor is governed by coexpression with one of three receptor activity-modifying proteins (RAMPs) (Buhlmann et al., 1999; Husmann et al., 2000; McLatchie et al., 1998; Hilairet et al., 2001; Oliver et al., 2001).”
BackgroundMethodResultInfluentialLiu, Y.-Z., Dvornyk, V., Lu, Y., Shen, H., Lappe, J. M., Recker, R. R., & Deng, H.-W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501164200 · Cited by 125
McIlvried, L. A., Atherton, M. A., Horan, N. L., Goch, T. N., & Scheff, N. N. (2022) · Advanced Biology · doi:10.1002/adbi.202200019 · Cited by 140
Calcitonin gene-related peptide (CGRP) and its role in hypertension
Smillie, S.-J., & Brain, S. D. (2011) · Neuropeptides · doi:10.1016/j.npep.2010.12.002 · Cited by 137
Evolution of secretin family GPCR members in the metazoa
Cardoso, J. C. R., Pinto, V., Vieira, F. A., Clark, M. S., & Power, D. M. (2006) · BMC Evolutionary Biology · doi:10.1186/1471-2148-6-108 · Cited by 126
“Accessory single transmembrane proteins (Receptor activity modifying proteins, RAMPs [56,57]) interact with both CAL and CGRP receptors and alter their affinity profile for the ligands (CAL, CGRP, adrenomodullin and amylin) [58,59].”
BackgroundCGRP: Sensory neuropeptide with multiple neurologic implications
Benarroch, E. E. (2011) · Neurology · doi:10.1212/wnl.0b013e31822550e2 · Cited by 141
García‐Nafría, J., & Tate, C. G. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023545 · Cited by 130
Edvinsson, L. I., Nilsson, E., & Jansen‐Olesen, I. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707134 · Cited by 126
“Their function and pharmacology are determined by the presence of receptor activity-modifying proteins (RAMPs) (McLatchie et al., 1998).”
BackgroundAutonomic control of blood pressure in mice: basic physiology and effects of genetic modification
Janssen, B. J. A., & Smits, J. F. M. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00714.2001 · Cited by 122
Raggo, C. M., Ruhl, R. A., McAllister, S. C., Koon, H. B., Dezube, B. J., Früh, K., & Moses, A. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2822 · Cited by 126
“Previously, work identifying the hormones calcitonin-related peptide or adrenomedullin as putative ligands (38) are no longer considered valid; thus, RDC1 is still considered an orphan receptor ( 39 , 40).”
BackgroundProtein–protein interactions at G-protein-coupled receptors
Milligan, G., & White, J. H. M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01801-0 · Cited by 141
Minireview: the melanocortin 2 receptor accessory proteins
Webb, T. R., & Clark, A. J. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0283 · Cited by 125
Chakravarty, P., Suthar, T. P., Coppock, H. A., Nicholl, C. G., Bloom, S. R., Legon, S., & Smith, D. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702975 · Cited by 122
“The values are generally consistent with published data though it should be noted that we ®nd a highly speci®c pattern of gene expression for RAMP-3 mRNA in the rat that was not seen in earlier work with human RNAs (McLatchie et al., 1998).”
BackgroundMethodResultInfluentialOehler, M. K., Norbury, C. J., Hague, S. J., REES, M. C. P., & Bicknell, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204422 · Cited by 133
“ADM has been shown to act through the G protein-coupled receptor calcitonin receptor-like receptor (CRLR), with a speci®city for ADM being conferred by the receptor associated modifying protein 2 (RAMP2) (Kamitani et al., 1999; McLatchie et al., 1998).”
BackgroundLu, J. T., Son, Y., Lee, J., Jetton, T. L., Shiota, M., Moscoso, L. M., Niswender, K. D., Loewy, A. D., Magnuson, M. A., Sanes, J. R., et al. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0767 · Cited by 128
Bomberger, J. M., Parameswaran, N., Hall, C. S., Aiyar, N., & Spielman, W. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413786200 · Cited by 121
Orphan G‐protein‐coupled receptors: the next generation of drug targets?
Wilson, S., Bergsma, D. J., Chambers, J. K., Muir, A. I., Fantom, K. G. M., Ellis, C. E., Murdock, P. R., Herrity, N. C., & Stadel, J. M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702238 · Cited by 124
“However, it has been shown more recently that accessory proteins appear to be necessary to allow this receptor to show CGRP responsiveness, so an alternative explanation may lie in di erential expression of such accessory proteins in HEK293 vs COS cells (McLatchie et al., 1998).”
BackgroundSmillie, S.-J., King, R., Kodji, X., Outzen, E. M., Pozsgai, G., Fernandes, E. S., Marshall, N. J., de Winter, P., Heads, R. J., Dessapt-Baradez, C., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02517 · Cited by 123
The putative β4-adrenergic receptor is a novel state of the β1-adrenergic receptor
Granneman, J. G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e199 · Cited by 121
“It is also conceivable that the aryloxypropanolamine sensitivity involves interaction of b1-AR with accessory proteins, perhaps in a manner similar to receptor activity modifying proteins (21, 24).”
BackgroundBooe, J. M., Walker, C. S., Barwell, J., Kuteyi, G., Simms, J., Jamaluddin, M. A., Warner, M. L., Bill, R. M., Harris, P. W., Brimble, M. A., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.018 · Cited by 122
“…to their cognate class B receptor, the calcitonin receptor-like receptor (CLR), is dependent on association of CLR with one of three accessory membrane proteins that determine ligand selectivity; receptor activity-modifying proteins (RAMPs) 1, 2, or 3 (Hong et al., 2012; McLatchie et al., 1998).”
Glucagon-Like Peptide-1 Augments Insulin-Mediated Glucose Uptake in the Obese State
Egan, J. M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3768 · Cited by 119
Comparison of the Effects of Calcitonin Gene-Related Peptide and Amylin on Osteoblasts
Dr. Cornish, J., Callon, K. E., Lin, C. Q., Xiao, C. L., Gamble, G. D., Cooper, G. J. S., & Reid, I. R. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.8.1302 · Cited by 121
“The recent work of McLatchie et al.((36)) has carried the area forward substantially.”
MethodInfluentialNew drugs in migraine treatment and prophylaxis: telcagepant and topiramate
Edvinsson, L. I., & Linde, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60323-6 · Cited by 130
Edvinsson, L. I. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2003.00719.x · Cited by 121
Yurugi-Kobayashi, T., Itoh, H., Schroeder, T., Nakano, A., Narazaki, G., Kita, F., Yanagi, K., Hiraoka‐Kanie, M., Inoue, E., Ara, T., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000234978.10658.41 · Cited by 132
Martin, S. C., Russek, S. J., & Farb, D. H. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0741 · Cited by 131
Hay, D. L., & Walker, C. S. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13064 · Cited by 129
“This complex is now known as the CGRP receptor.(8,53,55) The CLR/RAMP1 complex has been the focus of all efforts so far in the development of receptor-based CGRP blocking therapies for migraine.”
BackgroundCross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators
Meßlinger, K., Balcziak, L. K., & Russo, A. F. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02161-7 · Cited by 123
A high affinity nitrate transport system from Chlamydomonas requires two gene products
Zhou, J.-J., Fernández, E. M., Galván, A., & Miller, T. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01085-1 · Cited by 119
Chung, S., Funakoshi, T., & Civelli, O. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707606 · Cited by 115
“This has been shown in the case of the calcitonin GPCR, which necessitate the presence of RAMPs for inducing its signalling pathway (McLatchie et al., 1998; Hay et al., 2006).”
BackgroundCutting Edge: Expression of the C-C Chemokine Receptor CCR3 in Human Airway Epithelial Cells
Stellato, C., Brummet, M. E., Plitt, J. R., Shahabuddin, S., Baroody, F. M., Liu, M. C., Ponath, P. D., & Beck, L. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1457 · Cited by 118
“Alternatively, posttranscriptional regulation or existence of receptor-activity modifying protein-like proteins necessary for expression of mature membrane protein (25) may exist.”
BackgroundIntramembrane receptor–receptor interactions: a novel principle in molecular medicine
Fuxe, K., Canals, M., Torvinen, M., Marcellino, D., Terasmaa, A., Genedani, S., Leo, G., Guidolin, D., Diaz-Cabiale, Z., Rivera, A., et al. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-006-0589-0 · Cited by 118
“…noted that the receptor activity-modifying proteins (RAMP) regulate the pharmacology of the receptors for the calcitonin family of peptide hormones (McLatchie et al., 1998; see also Foord et al., 2005) like calcitonin gene-related peptide (CGRP), adrenomedullin (ADM) and intermedin (Roh et al.,…”
Oliver, K. R., Kane, S. A., Salvatore, C. A., Mallee, J. J., Kinsey, A. M., Koblan, K. S., Keyvan‐Fouladi, N., Heavens, R. P., Wainwright, A., Jacobson, M., et al. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01688.x · Cited by 118
“In agreement with functional data showing that CRLR and RAMP1 associate to bind CGRP (this study and McLatchie et al., 1998), RAMP1 mRNA was also abundantly expressed in cells of these regions (Figs 3 and 4).”
BackgroundMethodResultInfluentialHarzenetter, M. D., Novotny, A. R., Gais, P., Molina, C. A., Altmayr, F., & Holzmann, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.607 · Cited by 115
The clinical relevance of adrenomedullin: a promising profile?
Bunton, D. C., Petrie, M. C., Hillier, C., Johnston, F., & McMurray, J. J. V. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.07.002 · Cited by 128
Structural basis of G protein-coupled receptor function
Schöneberg, T., Schultz, G., & Gudermann, T. W. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00017-9 · Cited by 117
Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP
Riediger, T., Schmid, H. A., Lutz, T., & Simon, E. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.6.r1833 · Cited by 119
An escort for GPCRs: implications for regulation of receptor density at the cell surface
Achour, L., Labbé‐Jullié, C., Scott, M. G. H., & Marullo, S. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.009 · Cited by 124
Cluster headache pathophysiology — insights from current and emerging treatments
Wei, D. Y., & Goadsby, P. J. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00477-w · Cited by 118
Edvinsson, L. I., Alm, R., Shaw, D., Rutledge, R. Z., Koblan, K. S., Longmore, J., & Kane, S. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01532-1 · Cited by 115
Dackor, R., Fritz-Six, K., Smithies, O., & Caron, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703544200 · Cited by 114
Calcitonin gene-related peptide-containing pathways in the rat forebrain
Dobolyi, A., Irwin, S., Makara, G., Usdin, T. B., & Palkovits, M. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20618 · Cited by 110
“CGRP has been proposed to play a role in several spinal level functions including spinal nociceptive transmission and motoneuronal activity (Micevych and Kruger, 1992; van Rossum et al., 1997).”
BackgroundHilairet, S., Foord, S. M., Marshall, F. H., & Bouvier, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102722200 · Cited by 114
Self-citationRogers, M. E., Steinbrecht, R. A., & Vogt, R. G. (2001) · Cell and Tissue Research · doi:10.1007/s004410000305 · Cited by 113
Lupardus, P. J., Wilke, R. A., Aydar, E., Palmer, C. P., Chen, Y., Ruoho, A. E., & Jackson, M. B. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00527.x · Cited by 111
“The recently described receptor-activity-modifying protein (RAMP) has a single membrane-spanning segment and regulates the transport and functional activity of the calcitonin-receptor-like receptor (McLatchie et al. 1998).”
BackgroundMolecular Pharmacology of the Calcitonin Receptor
Purdue, B. W., Tilakaratne, N., & Sexton, P. M. (2002) · Receptors and Channels · doi:10.1080/10606820213681 · Cited by 113
Biological role of α-fetoprotein in cancer: prospects for anticancer therapy
Mizejewski, G. J. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.6.709 · Cited by 128
Nagae, T., Mukoyama, M., Sugawara, A., Mori, K., Yahata, K., Kasahara, M., Suganami, T., Makino, H., Fujinaga, Y., Yoshioka, T., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2390 · Cited by 117
An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth
Tsuruda, T., Kato, J., Kitamura, K., Kawamoto, M., Kuwasako, K., Imamura, T., Koiwaya, Y., Tsuji, T., Kangawa, K., & Eto, T. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00122-4 · Cited by 116
Allostery and biased agonism at class B G protein-coupled receptors
Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00049 · Cited by 112
Lamkhioued, B., Abdelilah, S. G., Hamid, Q. A., Mansour, N., Delespesse, G., & RENZI, P. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.537 · Cited by 112
“Alternatively, posttranscriptional regulation or existence of receptor activity-modifying proteins necessary for expression of mature membrane protein (52) may exist.”
BackgroundRamachandran, V., Arumugam, T., Hwang, R. F., Greenson, J. K., Simeone, D. M., & Logsdon, C. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3362 · Cited by 106
“In combination with RAMP1, CRLR has the highest affinity for calcitonin gene–related peptides, and in combination with RAMP2 or RAMP3, it prefers adrenomedullin (37).”
BackgroundKamohara, M., Matsuo, A., Takasaki, J., Kohda, M., Matsumoto, M., Matsumoto, S., Soga, T., Hiyama, H., Kobori, M., & Katou, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.088 · Cited by 111
Oehler, M. K., Hague, S. J., REES, M. C. P., & Bicknell, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205374 · Cited by 115
“Reverse transcription (RT)-polymerase chain reaction (PCR) CRLR and RAMP2 gene expression in RL95.”
BackgroundBell, D., & McDermott, B. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707494 · Cited by 115
“In addition, receptor activity-modifying proteins (RAMPs) act as molecular chaperones for trafficking of CL and CT from endoplasmic reticulum and Golgi apparatus to the cell surface and exert a pivotal influence over the receptors’ pharmacological characteristics (McLatchie et al., 1998).”
BackgroundPathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders
Ishimitsu, T., Ono, H., Minami, J., & Matsuoka, H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.004 · Cited by 119
Cottrell, G. S., Roosterman, D., Marvizon, J.-C., Song, B., Wick, E., Pikios, S., Wong, H., Berthelier, C., Tang, Y., Sternini, C., et al. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20669 · Cited by 104
“There are other reports of the generation of antibodies to peptide fragments of CLR and RAMP1 as well as purified CGRP receptors (Chauhan et al., 2004; Dong et al., 2003; Hagner et al., 2001, 2002a,b, 2003; Morara et al., 1998, 2000; Oliver et al., 2002; Wimalawansa, 1992; Ye et al., 1999).”
Background
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.